Vir Biotechnology, Inc.

Vir Biotechnology, Inc. - ROEverified

VIR

Price:

$9.16

Market Cap:

$1.54B

Vir Biotechnology, Inc. operates as an immunology company with commercialized products, dedicated to devising therapeutic solutions for the treatment and prevention of significant infectious diseases. Its pipeline features several key candidates: Sotrovimab (branded as Xevudy, or VIR-7832), a neutralizing monoclonal antibody for both treating and preventing SARS-CoV-2 infection; VIR-2218 and VIR-3434, aimed at hepatitis B virus; VIR-2482, targeting the prevention of influenza A virus; and VIR-1111, designed to prevent human immunodeficiency virus. The firm maintains a robust network of strategic partnerships and collaborations. These include grant support from organizations like the Bill & M...[Read more]

Industry

Biotechnology

IPO Date

2019-10-11

Stock Exchange

NASDAQ

Ticker

VIR

The ROE as of June 2026 (TTM) for Vir Biotechnology, Inc. (VIR) is -53.31%

According to Vir Biotechnology, Inc.’s latest financial reports and current stock price. The company's current ROE is -53.31%. This represents a change of 300.27% compared to the average of -13.32% of the last 4 quarters.

Vir Biotechnology, Inc. (VIR) Historical ROE (quarterly & annually)

How has VIR ROE performed in the past?

The mean historical ROE of Vir Biotechnology, Inc. over the last ten years is 0.40%. The current -53.31% ROE has changed -13340.71% with respect to the historical average. Over the past ten years (40 quarters), VIR's ROE was at its highest in in the December 2021 quarter at 36.68%. The ROE was at its lowest in in the March 2021 quarter at -25.95%.

Quarterly (TTM)
Annual

Average

0.40%

Median

-38.68%

Minimum

-57.23%

Maximum

101.36%

Vir Biotechnology, Inc. (VIR) ROE by Quarter and Year

Discovering the peaks and valleys of Vir Biotechnology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 26.14%

Maximum Annual ROE = 101.36%

Minimum Annual Increase = -255.81%

Minimum Annual ROE = -57.23%

Quarterly (TTM)
Annual
YearROEChange
2025-57.23%26.14%
2024-45.37%17.31%
2023-38.68%-255.81%
202224.82%-32.76%
202136.92%-188.61%
2020-41.66%1.11%
2019-41.20%-163.71%
201864.68%-36.19%

Vir Biotechnology, Inc. (VIR) Average ROE

How has VIR ROE performed in the past?

The current ROE of Vir Biotechnology, Inc. (VIR) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-47.09%

5-year avg

-15.91%

10-year avg

0.40%

Vir Biotechnology, Inc. (VIR) ROE vs. Peers

How is VIR’s ROE compared to its peers?

Vir Biotechnology, Inc.’s ROE is greater than Maravai LifeSciences Holdings, Inc. (-44.72%), greater than Iovance Biotherapeutics, Inc. (-50.17%), greater than Replimune Group, Inc. (-102.69%), greater than Prime Medicine, Inc. (-188.82%), greater than Ginkgo Bioworks Holdings, Inc. (-57.31%), greater than Geron Corporation (-28.90%), greater than LENZ Therapeutics, Inc. (-46.82%), less than YD Bio Limited Ordinary Shares (80.82%), greater than Day One Biopharmaceuticals, Inc. (-23.43%), greater than Kura Oncology, Inc. (-141.95%),

Build a custom stock screener for Vir Biotechnology, Inc. (VIR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vir Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vir Biotechnology, Inc. (VIR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vir Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Vir Biotechnology, Inc.'s ROE?

How is the ROE calculated for Vir Biotechnology, Inc. (VIR)?

What is the highest ROE for Vir Biotechnology, Inc. (VIR)?

What is the 3-year average ROE for Vir Biotechnology, Inc. (VIR)?

What is the 5-year average ROE for Vir Biotechnology, Inc. (VIR)?

How does the current ROE for Vir Biotechnology, Inc. (VIR) compare to its historical average?